Cytochalasin B (Phomin)
(Synonyms: 细胞松弛素B; Phomin) 目录号 : GC32890Cytochalasin B(细胞松弛素B)是一种可渗透细胞的真菌毒素,从Phoma属的子囊菌真菌中分离得到。
Cas No.:14930-96-2
Sample solution is provided at 25 µL, 10mM.
Cytochalasin B is a cyto-permeable mycotoxin, and it is isolated from an ascomycete fungus belonging to the Phoma genus[1-2]. Cytochalasin B is able to inhibit the formation of actin microfilaments through a direct effect on the polymerization of the cytoskeletal protein. By binding the fast-growing end of F-actin and interacting with capping proteins, influences the nucleation-elongation of actin microfilaments[3-4].
Cytochalasin B (0.1-10 µM; 0-72 h) influenced the metabolism, proliferation, and morphology of hASCs in a dose-dependent manner, in association with progressive disorganization of actin microfilaments[5]. Cytochalasin B is capable of inducing DNA fragmentation in a number of cells lines[6]. Cytochalasin B (10-8-10-1M; 24-96 h) effectively inhibited U251 cell proliferation in a dose- and time-dependent manner. Cytochalasin B increased the proportion of cells in the G2/M phase in a dose-dependent manner, thus increasing the mitotic index and decreasing CDC2 and cyclin B1 protein levels[7].
Cytochalasin B(Cytochalasins B was prepared in suspension form in 2% carboxymethyl cellulose 1% tween 20 (CMC/Tw); i.p.;10, 25, or 50 mg/kg; 8days ) dose-dependently increases the life expectancy of Balb/c mice bearing with P388/ADR leukemias[8].Cytochalasin B(5 µg/ml Cytochalasin B; 30 min) treatment of mouse oocytes during intracytoplasmic sperm injection (ICSI) increases embryo survival without impairment of development[9].
References:
[1]. Van Goietsenoven G, Mathieu V, et,al. In vitro growth inhibitory effects of cytochalasins and derivatives in cancer cells. Planta Med. 2011 May;77(7):711-7. doi: 10.1055/s-0030-1250523. Epub 2010 Nov 5. PMID: 21058241.
[2]. Trendowski M. Using cytochalasins to improve current chemotherapeutic approaches. Anticancer Agents Med Chem. 2015;15(3):327-35. doi: 10.2174/1871520614666141016164335. PMID: 25322987; PMCID: PMC4485394.
[3]. MacLean-Fletcher S, Pollard TD. Mechanism of action of cytochalasin B on actin. Cell. 1980 Jun;20(2):329-41. doi: 10.1016/0092-8674(80)90619-4. PMID: 6893016.
[4]. Flanagan MD, Lin S. Cytochalasins block actin filament elongation by binding to high affinity sites associated with F-actin. J Biol Chem. 1980 Feb 10;255(3):835-8. PMID: 7356663.
[5]. Bianconi E, Tassinari R, et,al. Cytochalasin B Modulates Nanomechanical Patterning and Fate in Human Adipose-Derived Stem Cells. Cells. 2022 May 12;11(10):1629. doi: 10.3390/cells11101629. PMID: 35626666; PMCID: PMC9139657.
[6]. Kolber MA, Broschat KO, et,al. Cytochalasin B induces cellular DNA fragmentation. FASEB J. 1990 Sep;4(12):3021-7. doi: 10.1096/fasebj.4.12.2394319. PMID: 2394319.
[7]. Tong ZG, Liu N, et,al. Cytochalasin B inhibits the proliferation of human glioma U251 cells through cell cycle arrest and apoptosis. Genet Mol Res. 2014 Dec 19;13(4):10811-22. doi: 10.4238/2014.December.19.2. PMID: 25526201.
[8]. Trendowski M, Mitchell JM, et,al. Chemotherapy with cytochalasin congeners in vitro and in vivo against murine models. Invest New Drugs. 2015 Apr;33(2):290-9. doi: 10.1007/s10637-014-0203-5. Epub 2015 Jan 7. PMID: 25563824; PMCID: PMC4387261.
[9].Hu LL, Shen XH, et,al. Cytochalasin B treatment of mouse oocytes during intracytoplasmic sperm injection (ICSI) increases embryo survival without impairment of development. Zygote. 2012 Nov;20(4):361-9. doi: 10.1017/S0967199411000438. Epub 2011 Aug 15. PMID: 21838963.
Cytochalasin B(细胞松弛素B)是一种可渗透细胞的真菌毒素,从Phoma属的子囊菌真菌中分离得到[1-2]。它能够通过直接影响细胞骨架蛋白的聚合来抑制肌动蛋白微丝的形成。通过结合F-肌动蛋白的快速生长端并与封盖蛋白相互作用,影响肌动蛋白微丝的成核伸长[3-4]。
Cytochalasin B (0.1-10 µM;0-72 h)以剂量依赖的方式影响hASCs细胞的代谢、增殖和形态,这与肌动蛋白微丝的逐渐解体有关[5]。Cytochalasin B能够在许多细胞系中诱导DNA断裂[6]。Cytochalasin B (10-8-10-1M;24-96 h)有效抑制U251细胞增殖。Cytochalasin B以剂量依赖的方式增加G2/M期细胞的比例,从而增加有丝分裂指数,降低CDC2和cyclin B1蛋白水平[7]。
Cytochalasin B (Cytochalasins B was prepared in suspension form in 2% carboxymethyl cellulose 1% tween 20 (CMC/Tw); i.p.;10, 25, or 50 mg/kg; 8days)剂量依赖性地增加P388/ADR白血病Balb/c小鼠的预期寿命[8]。对小鼠卵母细胞进行胞浆内精子注射(ICSI)期间的Cytochalasin B(5 µg/ml Cytochalasin B; 30 min) 处理增加了胚胎的存活率,而不影响发育[9]。
Cell experiment [1]: | |
Cell lines |
Human mesenchymal stem cells (hMSCs) |
Preparation Method |
Cells were cultured in the presence of Cytochalasin B or 0.05% DMSO. |
Reaction Conditions |
0.1-10 µM; 0-72 h |
Applications |
Cytochalasin B influenced the metabolism, proliferation, and morphology of hASCs in a dose-dependent manner. |
Animal experiment [2]: | |
Animal models |
Balb/c mice (bearing P388/ADR leukemias) |
Preparation Method |
Mice (bearing P388/ADR leukemias) were administered with Cytochalasin B on Days 1-8. |
Dosage form |
Cytochalasins B was prepared in suspension form in 2% carboxymethyl cellulose 1% tween 20 (CMC/Tw); i.p.;10, 25, or 50 mg/kg; 8days |
Applications |
Cytochalasin B dose-dependently increases the life expectancy of Balb/c mice bearing with P388/ADR leukemias. |
References: [1]. Bianconi E, Tassinari R, et,al. Cytochalasin B Modulates Nanomechanical Patterning and Fate in Human Adipose-Derived Stem Cells. Cells. 2022 May 12;11(10):1629. doi: 10.3390/cells11101629. PMID: 35626666; PMCID: PMC9139657. |
Cas No. | 14930-96-2 | SDF | |
别名 | 细胞松弛素B; Phomin | ||
Canonical SMILES | O=C1N[C@@H](CC2=CC=CC=C2)[C@@]3([H])[C@]14[C@](/C=C/C[C@H](C)CCC[C@@H](O)/C=C/C(O4)=O)([H])[C@H](O)C([C@H]3C)=C | ||
分子式 | C29H37NO5 | 分子量 | 479.61 |
溶解度 | DMF: 30 mg/ml DMF:PBS (pH 7.2) (1:20): 0.05 mg/ml DMSO: 20 mg/ml Ethanol: 20 mg/ml | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.085 mL | 10.4251 mL | 20.8503 mL |
5 mM | 0.417 mL | 2.085 mL | 4.1701 mL |
10 mM | 0.2085 mL | 1.0425 mL | 2.085 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet